Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03921450Completed
Randomised, double-blind trial (4 arms), sponsored by University of Bern. Primary endpoints: Proportion of responders at 3 weeks and Salpetriere Retardation Rating Scale at 24 weeks. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03921450.